Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression
Kwon Joong Na
Seoul National University
Korea
A-0184
14:55-15:05
Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy
Duk Ki Kim
Chungnam National University
Korea
A-0105
15:05-15:15
Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC)
Jong Yeob Kim
Feinberg School of Medicine, Northwestern University
USA
A-0127
15:15-15:25
Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract
Chaeuk Chung
Chungnam National University
Korea
A-0057
15:25-15:35
Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer
Bo-Guen Kim
Kangbuk Samsung Medical Center
Korea
A-0042
15:35-15:45
Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity
Cheol-Kyu Park
Chonnam National University
Korea
Oral Presentation 2
November 8 (Fri), 09:10-10:10
ROOM C (Grand Ballroom 1)
Oral Present
Abstract No.
Presentation Time
Abstract Title
Presenter Name
Affiliation
Country
A-0226
09:10-09:20
Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study
Junghee Lee
Samsung Medical Center
Korea
A-0214
09:20-09:30
Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial
Sung Yong Lee
Korea University
Korea
A-0204
09:30-09:40
What Is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (>5 cm) Non-Small Cell Lung Cancer?
Ye Jin Yoo
Asan Medical Center
Korea
A-0108
09:40-09:50
Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series
Young Chae
Northwestern University Feinberg School of Medicine
USA
A-0069
09:50-10:00
Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer
Sangjoon Park
Severance Hospital
Korea
A-0046
10:00-10:10
Refining patient selection for prophylactic cranial irradiation in limited-stage small-cell lung cancer: Insights from a Korean multi-institutional cohort study
Hye In Lee
Asan Medical Center
Korea
Oral Presentation 3
November 8 (Fri), 10:25-11:25
ROOM C (Grand Ballroom 1)
Oral Present
Abstract No.
Presentation Time
Abstract Title
Presenter Name
Affiliation
Country
A-0080
10:25-10:35
Real-world insights: Treatment patterns and overall survival in patients with small-cell lung cancer in South Korea a single center experience
Sehhoon Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Korea
A-0196
10:35-10:45
AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients
Kwon Joong Na
Seoul National University
Korea
A-0167
10:45-10:55
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients
Jae Ho Cho
Chonnam National University Medical School
Korea
A-0230
10:55-11:05
Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1
Ji Eun Shin
The Catholic University of Korea St. Vincent's Hospital
Korea
A-0131
11:05-11:15
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer
Yang-Gun Suh
National Cancer Center
Korea
A-0035
11:15-11:25
Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: radiomic prediction